Sudler & Hennessey promotes Max Jackson

pharmafile | February 24, 2010 | Appointment | Medical Communications Sudler & Hennessey, appointment, medical communications 

Max Jackson has been promoted to chief executive, EMEA and APAC, at advertising agency Sudler & Hennessey (S&H).

In his new role Max will add responsibility for the Asia Pacific (APAC) region to his current EMEA remit, and oversee more than 30 healthcare offices on three continents.

“The APAC region has probably the largest growth potential in healthcare, as well as presenting a number of significant challenges, both geographical, socio-economic and technological,” Max said.

Advertisement

“We are looking forward to continuing our leadership in this region, and to a rich exchange of ideas between the established and developing markets.”

Max has worked in healthcare communications for 19 years, both client-side and in agencies, spending the last eight years in global leadership roles at large healthcare communications networks.

Related Content

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The Gateway to Local Adoption Series

Latest content